Key Challenges and Potential Solutions for Optimizing Downstream Bioprocessing Production
The term “optimize” is often applied to complex manufacturing, automation and business processes and implies that the most efficient function of all the elements of a process – technologies, sequences and procedures – has not been achieved. While no method can be perfect, every process can benefit from a careful consideration where new thinking, new techniques and new technology can yield significant improvements.
The dramatic growth in the use of biologics across multiple therapeutic applications and categories will only continue to increase. As the demand for these drugs accelerates, there are growing concerns about their cost and availability. Biologics manufacturers are investigating ways to address these concerns – and downstream production in bioprocessing operations is one such area.
Senior Vice President, Business Development and Commercial Operations – Biopharma Production
Claudia Berrón, is Senior Vice President, Business Development and Commercial Operations – Biopharma Production. Berrón had two decades of experience in B2B strategic marketing covering ideation, value proposition strategies, market segmentation, marketing and sales plan, through product launch. Berrón holds an MBA degree from the University of North Carolina, Kenan-Flagler Business School, Chapel Hill, and a BA degree from Monterrey Institute of Technology in Mexico City.
Dr. Nandu Deorkar
Vice President, Research & Development – Biopharma Production
During his more than 25-year career in materials technology research & development, Dr Deorkar has worked on various aspects of chemical/polymer R&D, drug development, formulation, drug delivery technologies, process development, and technology transfer. Dr Deorkar earned his PhD in chemistry from the Indian Institute of Technology, Bombay, and his MBA from Fairleigh Dickinson University, New Jersey (USA).
From the small-scale bench to full commercial manufacturing, we enable our customers to reach the market with new treatments for patients, faster and safer. Learn more about our offering for biopharmaceutical manufacturing.